News & Media - Wolfe Research, LLC
Jun 24, 2024 · Wolfe Research has established a reputation for equity research. Our analysts are regularly featured in top news articles and media outlets.
Wolfe Research Raises Concerns Over Advanced Micro Devices, …
1 day ago · We recently compiled a list of the 9 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against ...
Wolfe Research Sees Bright Future for Twilio (TWLO) with Raised …
2 days ago · Wolfe Research Sees Bright Future for Twilio (TWLO) with Raised Price Target and Outperform Rating. ... READ ALSO: Top 10 AI News You Shouldn’t Miss and 10 AI Stocks Taking Wall Street by Storm .
Wolfe Research: “Our Best Guess Is That AMD Won’t Be In
3 days ago · Wolfe Research begins its latest investment note by highlighting the lack of visibility on AMD's AI-related sales: "While forecasts can change as CY25 proceeds, we don’t think there’s enough ...
Home - Wolfe Research, LLC
3 days ago · With a team of over 30 analysts, Wolfe covers 750+ companies across over 100 industries. Wolfe Research, LLC is a premier independent sell-side research firm with a commitment to best-in-class content and ongoing strategic growth.
Wolfe sees AMD AI revenue $3B below expectations in 2025
4 days ago · Based on the checks, Wolfe expects “only” $7B of AI revenue in 2025 for AMD, below what it believes is a buy-side expectation of $10B. The firm also expect PC to be less than seasonal in Q1 ...
News & Media Archive - Wolfe Research, LLC
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk. GM, Stellantis Catch Downgrades, Ford Reports Sales, and Tesla Stock Jumps. How to Understand the Moves.
Wolfe Research Upgrades Warner Bros. Discovery as Max Sees …
Nov 11, 2024 · Wolfe Research has upgraded Warner Bros. Discovery (WBD, Financials) to "peer perform" from "underperform," citing a balanced risk/reward outlook despite Warner Bros. Discoverys $40 billion in...
Wolfe Research starts Regeneron at Outperform, sees ‘attractive …
Nov 14, 2024 · Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had pressured Regeneron from all-time highs, and the...
Wolfe Research: Avoid these possible earnings blowups - CNBC
Jan 10, 2024 · There are some names this upcoming earnings season investors may want to steer clear from, according to Wolfe Research.
- Some results have been removed